Atlas Trials

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Clinical trial NCT02015780 · WITHDRAWN

Trial details

NCT number
NCT02015780
Sponsor
Takeda
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusChronic Kidney Disease
Start date
2013-12-01
Primary completion
2016-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.